Search

La FDA ha otorgado la aprobación acelerada a zenocutuzumab para el tratamiento de pacientes con cáncer de páncreas avanzado o cáncer pulmonar de células no pequeñas (CPCNP) con una alteración denominada fusión del gen NRG1, con base en un ensayo clínico de fase 2, liderado por una investigadora de MSK.

… Thursday, February 6, 2025 Zenocutuzumab (Bizengri ® ) es eficaz para tratar a muchos pacientes con  cáncer de páncreas avanzado o  cáncer pulmonar de células no pequeñas (CPCNP)  que presentan una alteración llamada fusión del gen  NRG1  y cuya enfermedad progresó después de otros tratamientos, según

James P. Allison, Chair of the Immunology Program in the Sloan Kettering Institute, has been elected a member of the Institute of Medicine.

… Tuesday, January 1, 2008 Summary James P. Allison, Chair of the Immunology Program in the Sloan Kettering Institute, has been elected a member of the Institute of Medicine. James P. Allison, Chair of the Immunology Program in the Sloan Kettering Institute , has been elected a member of the Institute

Increased progression-free survival and a better quality of life were seen in HER2-negative metastatic breast cancer patients with a BRCA mutation who were treated with olaparib versus a single-agent chemotherapy.

… Sunday, June 4, 2017 The first phase III trial of a PARP inhibitor used to treat breast cancer reported promising data at the annual meeting of the American Society of Clinical Oncology (ASCO). Mark Robson, MD , Clinic Director of the Clinical Genetics Service and medical oncologist at Memorial Sloan

Meet MSK Clinical Nurse Margaret Bediones of MSK's Ralph Lauren Center in Harlem: “I love talking to people to educate them about the importance of cancer prevention and screening.”

… Friday, June 6, 2025 For MSK nurse Margaret Bediones, RN , taking care of people extends far beyond the walls of the MSK Ralph Lauren Center (RLC) in Harlem . She is committed to improving the health of people from underserved areas across New York City.   Born in the Philippines, Margaret’s journey

Dr. Diane Reidy-Lagunes speaks with Dr. John Mulhall, Director of the Male Sexual and Reproductive Medicine Program at MSK and editor-in-chief of The Journal of Sexual Medicine, to discuss the impacts of cancer and its treatment on men’s sexual health.

… Thursday, March 3, 2022 Men’s sexual dysfunction is common during cancer treatment, so why doesn’t anyone talk about it? The medical team treating a cancer too often fails to address the potential impact on the patient’s sex life, despite the fact that it can be essential for emotional well-being. If

Learn about a promising drug that could be the first new treatment option for low-grade gliomas in more than 20 years.

… Monday, June 10, 2024 Alicia Kalogeropoulos had everything she wanted in her life at age 27: a loving husband, a first house, and a meaningful career as a nurse anesthetist. One day she tripped at home and hit her head. Fearing a concussion, Alicia’s husband, Alex, took her to the emergency room. A scan

In 2024, Fred’s Team runners and donors brought in $8,529,723 to accelerate life-changing cancer research at Memorial Sloan Kettering Cancer Center.

… Friday, January 17, 2025 Fred’s Team, the official running program of Memorial Sloan Kettering Cancer Center (MSK), proudly announces another record-breaking year of fundraising in support of MSK’s mission of ending cancer for life. In 2024, Fred’s Team runners and donors raised $8,529,723 to accelerate

Memorial Sloan Kettering’s 41st annual ceremony recognized graduates and award winners with an online event.

… Friday, May 29, 2020 Summary Nobel Laureate James Allison addressed the eight graduates of the Gerstner Sloan Kettering Graduate School of Biomedical Sciences with an online commencement address. Memorial Sloan Kettering’s 41st annual Academic Convocation and Commencement ceremony, held on May 27, looked

Learn more about the Neurology Multidisciplinary Care Clinic, which aims to help people with brain cancer and offer hope for their families.

… Friday, October 12, 2018 Gayle Rawlins-Peters and Anastasia Zankowsky Gayle Rawlins-Peters (left), a member of the case management team, and clinical social worker Anastasia Zankowsky are part of the Multidisciplinary Care Clinic. MSK neurologist Elena Pentsova Neurologist Elena Pentsova is co-director

Some of the first clinical trials testing immunotherapy for the treatment of sarcoma are now under way at MSK. Here’s a snapshot of where the research stands.

… Monday, January 22, 2018 Summary Soft tissue sarcoma , a diverse group of cancers that arise in the body’s connective tissue, is difficult to treat after it has spread. MSK clinicians are investigating the use of immunotherapy to treat this disease. The main approaches involve checkpoint inhibitors and